Biology isn’t
the barrier. Treatment is.
AlleleRx Therapeutics is pioneering one‑time, durable gene therapies to change the lives of children and families with Congenital Disorders of Glycosylation (CDG).
PMM2-CDG is the most common CDG, a life‑threatening pediatric disease with no approved therapies.
We are working on that.